Understanding how nicotine addiction affects the brain and exploring new treatments
Neuroinflammatory and glutamatergic mechanisms of nicotine seeking
This study is looking at how nicotine affects the brain and what makes people crave it, while also testing if a supplement called N-acetylcysteine can help reduce those cravings and support recovery for anyone struggling with nicotine addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10684702 on NIH RePORTER |
What this research studies
This research investigates the biological mechanisms behind nicotine addiction, focusing on how nicotine affects brain regions related to reward and relapse. It examines the role of glutamate, a neurotransmitter, in nicotine-seeking behavior and how exposure to nicotine-related cues can trigger relapse. The study also explores the potential of N-acetylcysteine (NAC), an antioxidant, to reduce nicotine cravings by restoring certain brain functions and reducing inflammation. Patients may benefit from insights into new therapeutic approaches for nicotine addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with nicotine addiction or those who have a history of nicotine use.
Not a fit: Patients who do not use nicotine or have never been addicted to nicotine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help individuals overcome nicotine addiction and reduce relapse rates.
How similar studies have performed: Previous research has shown promising results with similar approaches, particularly in the use of NAC for addiction treatment.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Gipson-Reichardt, Cassandra D — University of Kentucky
- Study coordinator: Gipson-Reichardt, Cassandra D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.